Acute lymphoblastic leukemia (ALL) in adults: disparities in treatment intervention based on access to treatment facility.

Adult acute lymphoblastic leukemia (ALL) is associated with poor outcomes. We evaluated differences by facility type in the parameters of 6766 adult ALL patients ≥ 40 years of age diagnosed from 2004 to 2015 in the National Cancer DataBase (NCDB) and survival outcomes using two-sample -tests or chi-square tests and Cox proportional hazards models. Those treated in academic facilities were younger (mean 58.5 versus 61.7 years,  < 0.001), Black (8.1% versus 5.6%,  < 0.001), had private insurance (50.9% versus 44.0%,  < 0.001), and more likely to receive chemotherapy (93.2% versus 81.4%,  < 0.001), any radiotherapy (14.9% versus 7.3%,  < 0.001), stem cell transplant (9.4% versus 2.5%,  < 0.001), or total body irradiation (TBI) (11.3% versus 4.3%,  < 0.001). Patients treated at an academic facility had a higher hazard of death (<.05) while those that received any chemotherapy or TBI or CNS radiation had a lower risk of death (all  < 0.05). These parameters should be evaluated in future studies.